Use of Antithrombotic Agents Among U.S. Stroke Survivors, 2000–2006

« Previous Next »American Journal of Preventive Medicine
Volume 38, Issue 1 , Pages 47-53, January 2010

Eric M. Cheng, MD, MS
- Department of Neurology, Health Services Research Program, David Geffen School of Medicine, University of California, Los Angeles, California
- Department of Neurology, VA Greater Los Angeles Healthcare System, Los Angeles, California
- HSR&D Center of Excellence, VA Greater Los Angeles Healthcare System, Sepulveda, California
- Address correspondence and reprint requests to: Eric M. Cheng, MD, MS, VA Greater Los Angeles Healthcare System, Department of Neurology, 11301 Wilshire Boulevard, Building 500, ML 127, Los Angeles CA 90073
Stanley N. Cohen, MD
- Stroke Prevention Program, Nevada Neurosciences Institute at Sunrise, Las Vegas, Nevada
Martin L. Lee, PhD
- Department of Biostatistics, UCLA School of Public Health, Los Angeles, California
- HSR&D Center of Excellence, VA Greater Los Angeles Healthcare System, Sepulveda, California
Stefanie D. Vassar, MS
- Department of Neurology, Health Services Research Program, David Geffen School of Medicine, University of California, Los Angeles, California
- Department of Neurology, VA Greater Los Angeles Healthcare System, Los Angeles, California
Alex Y. Chen, MD, MS
- Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California